Skip to content

Aperio AT2 DX System

by Leica Biosystems Imaging, Inc.

510(k) K190332

Aperio AT2 DX System is a medical device (FDA Class II; FDA product code PSY, Whole Slide Imaging System) made by Leica Biosystems Imaging, Inc., cleared under FDA 510(k) K190332 on 20 May 2019, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK190332 Date20 May 2019ClearedStatusActive

Official records

From the FDA record

Received by the FDA
14 Feb 2019
FDA decision
20 May 2019 (Substantially Equivalent)
FDA review time
95 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K190332 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
PSY
Device class
Class II
Regulation
21 CFR Part 864.3700
Advisory committee
Pathology
FDA decision
SESE Substantially Equivalent

Devices cleared under K190332

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K190332
UDI-DISize and differences
Aperio AT2 DX Scanner 23AT2DX
Leica Biosystems Imaging, Inc.
23AT2DX00815477020259 —No longer on the market

Similar devices

Other devices filed under FDA product code PSY (Whole Slide Imaging System).

Other devices from Leica Biosystems Imaging, Inc.

See all devices from Leica Biosystems Imaging, Inc. →